Department of Bioresources, School of Biological Sciences, University of Kashmir, Srinagar, J&K, India.
Breast Cancer. 2021 May;28(3):539-555. doi: 10.1007/s12282-021-01231-2. Epub 2021 Mar 4.
Macrophages are phagocytic sentinel cells of the immune system that are central to both innate and adaptive immune responses and serve as the first line of defense against pathogenic insults to tissues. In the tumor microenvironment, tumor-derived factors induce monocyte polarization towards a pro-tumor phenotype. The pro-tumor macrophages regulate key steps in tumorigenicity including tumor growth, angiogenesis, immune suppression, and metastasis. Macrophage infiltration in solid tumors correlates with poor prognosis and resistance to chemotherapy in most cancers. Here in this review, we will shed light on tumor-associated macrophages (TAMs) in regulating tumorigenicity and TAMs as a prognostic biomarker. Also, we will review the recent advances in targeting TAMs to increase the prognosis of cancer patients.
巨噬细胞是免疫系统的吞噬性哨兵细胞,它们是先天和适应性免疫反应的核心,也是抵御组织病原体侵袭的第一道防线。在肿瘤微环境中,肿瘤衍生的因子诱导单核细胞向促肿瘤表型极化。促肿瘤巨噬细胞调节肿瘤发生的关键步骤,包括肿瘤生长、血管生成、免疫抑制和转移。在大多数癌症中,实体瘤中的巨噬细胞浸润与预后不良和化疗耐药相关。在这篇综述中,我们将阐述肿瘤相关巨噬细胞(TAMs)在调节肿瘤发生中的作用以及 TAMs 作为预后生物标志物的作用。此外,我们还将回顾靶向 TAMs 以提高癌症患者预后的最新进展。